Go Pro

U.S. Physical Therapy (NYSE:USPH) Trading Down 4.8% - Here's Why

U.S. Physical Therapy logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • U.S. Physical Therapy shares fell 4.8% to about $78.81, with trading volume roughly 18% below the average session level.
  • The decline followed the company’s latest earnings report, which showed adjusted earnings of $0.75 per share—$0.06 below estimates—despite revenue rising 8.5% year over year to $214.06 million.
  • Analysts remain generally positive, with a “Moderate Buy” consensus and an average price target of $99.50; the company also announced a quarterly dividend of $0.46 per share, yielding about 2.3%.
  • MarketBeat previews the top five stocks to own by September 1st.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report)'s stock price traded down 4.8% during trading on Friday . The company traded as low as $78.68 and last traded at $78.8050. Approximately 175,878 shares traded hands during mid-day trading, a decline of 18% from the average session volume of 215,526 shares. The stock had previously closed at $82.76.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Zacks Research upgraded shares of U.S. Physical Therapy from a "strong sell" rating to a "hold" rating in a research report on Wednesday, May 27th. Barrington Research boosted their target price on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an "outperform" rating in a research note on Monday. Weiss Ratings restated a "hold (c-)" rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. Citigroup restated an "outperform" rating on shares of U.S. Physical Therapy in a research report on Monday. Finally, Citizens Jmp reaffirmed a "market outperform" rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $99.50.

Get Our Latest Stock Analysis on U.S. Physical Therapy

U.S. Physical Therapy Stock Performance

The business has a fifty day moving average of $71.75 and a 200-day moving average of $74.03. The company has a market cap of $1.20 billion, a PE ratio of 473.07, a P/E/G ratio of 2.25 and a beta of 1.13. The company has a current ratio of 1.27, a quick ratio of 1.19 and a debt-to-equity ratio of 0.48.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.75 earnings per share for the quarter, missing analysts' consensus estimates of $0.81 by ($0.06). U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.The business had revenue of $214.06 million during the quarter, compared to the consensus estimate of $211.36 million. During the same quarter in the prior year, the business posted $0.81 earnings per share. U.S. Physical Therapy's quarterly revenue was up 8.5% compared to the same quarter last year. Equities research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.96 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 21st will be given a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Friday, August 21st. U.S. Physical Therapy's payout ratio is presently 1,082.35%.

Insider Buying and Selling

In related news, Director Peter Francis Minan bought 492 shares of the company's stock in a transaction dated Monday, June 8th. The stock was purchased at an average cost of $63.14 per share, with a total value of $31,064.88. Following the transaction, the director owned 2,923 shares in the company, valued at approximately $184,558.22. This trade represents a 20.24% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.40% of the company's stock.

Hedge Funds Weigh In On U.S. Physical Therapy

Institutional investors have recently bought and sold shares of the stock. Hantz Financial Services Inc. lifted its holdings in U.S. Physical Therapy by 56.4% in the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company's stock worth $29,000 after buying an additional 132 shares during the period. Huntington National Bank raised its position in shares of U.S. Physical Therapy by 15.4% in the 4th quarter. Huntington National Bank now owns 1,052 shares of the company's stock worth $82,000 after acquiring an additional 140 shares in the last quarter. Osaic Holdings Inc. raised its position in shares of U.S. Physical Therapy by 1.6% in the 2nd quarter. Osaic Holdings Inc. now owns 10,447 shares of the company's stock worth $817,000 after acquiring an additional 166 shares in the last quarter. Snowden Capital Advisors LLC lifted its stake in shares of U.S. Physical Therapy by 3.6% in the 2nd quarter. Snowden Capital Advisors LLC now owns 5,600 shares of the company's stock valued at $438,000 after purchasing an additional 195 shares during the period. Finally, Janney Montgomery Scott LLC lifted its stake in shares of U.S. Physical Therapy by 6.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 3,381 shares of the company's stock valued at $253,000 after purchasing an additional 212 shares during the period.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc NYSE: USPH is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines